Atlas Trials

Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects

Clinical trial NCT02886884 · COMPLETED

Trial details

NCT number
NCT02886884
Sponsor
Joshua M Hare
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2017-10-20
Primary completion
2019-08-26
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.